Mutations in thepolGene of Human Immunodeficiency Virus Type 1 in Infected Patients Receiving Didanosine and Hydroxyurea Combination Therapy
Authors:
- Julianna LisziewiczJLJulianna Lisziewicz
- Franco LoriFLFranco Lori
Open Access
- 1 October 1997
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 176 (4) , 899-903
Abstract
The pattern of mutations in the reverse transcriptase (RT) of human immunodeficiency virus type 1 (HIV-1) strains that confer resistance to didanosinKeywords
This publication has 1 reference indexed in Scilit:
- Mutated K65R recombinant reverse transcriptase of human immunodeficiency virus type 1 shows diminished chain termination in the presence of 2',3'-dideoxycytidine 5'-triphosphate and other drugs.Proceedings of the National Academy of Sciences, 1995